Skip to search formSkip to main contentSkip to account menu

0.5 ML ustekinumab 90 MG/ML Prefilled Syringe

Known as: USTEKINUMAB 45MG/0.5ML INJ 0.5ML SYR, ustekinumab 45 MG in 0.5 mL Prefilled Syringe, USTEKINUMAB 45MG/0.5ML INJ,SYR,0.5ML 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Immunosuppressive Agents
Prefilled Syringeustekinumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Psoriasis et grossesse à l’heure des traitements biologiques : À propos d’un cas de grossesse sous ustekinumab
We report the case of a successful delivery following exposure to ustekinumab during pregnancy. Though psoriasis is not uncommon… 
2011
2011
Nécrose cutanée sous ustekinumab : une alerte
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)